Pseudomembranous enterocolitis: a historical and clinical review

Diseases of the Colon and Rectum
T W O'Connor

Abstract

Pseudomembranous enterocolitis (PMEC) was first documented in 1893. Since this initial description, confusion has reigned in the medical literature concerning its nature and differentiation from such entities as necrotizing enterocolitis and staphylococcal enterocolitis. Since the 1950s, volumes have been written on PMEC and its association with a multitude of different antibiotics. PMEC has generally been used as somewhat of a "wastebasket" designation, being applied to any postoperative patient who develops significant diarrhea while on broad-spectrum antibiotics. More recently, a resurgence of interest in PMEC has led to its recognition as a specific disease entity and to a greater understanding of its etiology. The current review traces the history of PMEC, distinguishes if from similar disease processes, and describes its clinical presentation, diagnosis, and management. PMEC is particularly distinguished from antibiotic-associated diarrhea and certain forms of antibiotic-associated colitis.

References

May 20, 1978·Lancet·H E LarsonS P Borriello
Sep 30, 1978·Lancet·R B TofflerM I Burrell
Apr 15, 1978·Lancet·W L GeorgeS M Finegold
Apr 1, 1975·The American Journal of Digestive Diseases·F J Tedesco
Dec 1, 1973·Lancet·A J ScottA R Kerr
Oct 1, 1974·Annals of Internal Medicine·F J TedescoD H Alpers
Mar 16, 1973·The Medical Letter on Drugs and Therapeutics
Aug 1, 1973·Radiology·R L Schapiro, A Newman
Feb 15, 1974·Drug and Therapeutics Bulletin
Aug 1, 1974·Archives of Internal Medicine·F E PittmanC D Humphrey
Apr 11, 1974·The New England Journal of Medicine·F J TedescoD H Alpers
Jun 1, 1956·A.M.A. Archives of Surgery·J V PROHASKAT S NELSEN
Sep 1, 1956·Annals of Internal Medicine·C R NEWMAN
Jul 1, 1958·The British Journal of Surgery·A W KAYA J WATSON
Jun 1, 1963·Annals of Surgery·W A ALTEMEIERE O HILL
Jun 1, 1965·Gut·S J Goulston, V J McGovern
Aug 1, 1948·The Surgical Clinics of North America·C F DIXON, R E WEISMANN

❮ Previous
Next ❯

Citations

Jan 1, 1984·Gastrointestinal Radiology·D BrunnerP Haney
Dec 1, 1986·Diseases of the Colon and Rectum·J M Church, V W Fazio
Mar 1, 1984·Journal of Clinical Pathology·A KingR E Warren
Jul 31, 1998·Postgraduate Medical Journal·Y K Viswanath, C D Griffiths
Apr 1, 1984·American Journal of Surgery·J M RosenbergL Mullany

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.